Bufuralol is a non-selective beta-adrenergic blocker historically used for hypertension and arrhythmia, and now more commonly encountered as a CYP2D6 substrate probe compound in in vitro drug metabolism studies. Simson Pharma's Bufuralol reference standard supports this pharmaceutical metabolism-research application.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bufuralol Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.